 OUTLINE: This is an open-label, randomized, multicenter study. Patients are stratified according to participating center, lactic dehydrogenase level normal vs abnormal, and WHO performance status 0 vs 1 vs 2. Patients are randomized to 1 of 2 treatment arms. 